When Fetal Anomalies Lead to Prognostic Clarification: An Underrecognized Application of Exome Sequencing
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70239 ↗At a glance
Journal article in Prenatal Diagnosis, 2026. Written by Jonathan Rips and 8 co-authors. Institution: Department of Genetics, Hadassah Medical Center, Jerusalem, Israel. Major MEDLINE topics: Exome Sequencing, Prenatal Diagnosis, Fetus, Congenital Abnormalities. 25 references.
Abstract (original language)
Objectives
To describe a cohort of fetuses with abnormal prenatal findings in whom exome sequencing (ES) identified genetic diagnoses that refined prognostic assessment and reduced prognostic uncertainty.
Methods
We retrospectively reviewed all fetal ES studies performed at our center between 2017 and 2025 for structural or biochemical abnormalities. Cases with a definitive molecular diagnosis were identified, and those with predicted mild, isolated, transient, or treatable phenotypes were classified as having comparatively favorable prognostic implications. Clinical findings and expected postnatal outcomes were analyzed.
Results
Among 1692 fetuses undergoing ES, a molecular diagnosis was identified in 291 (17%). Of these, five cases (∼2%) were considered reassuring: isolated postaxial polydactyly due to a GLI1 variant; X‐linked ichthyosis (STS) in a fetus with low estriol; isolated situs inversus; CFAP52‐related situs inversus totalis; and MAGED2‐associated transient antenatal Bartter syndrome. In all cases, ES refined prognosis and reduced the likelihood of severe syndromic conditions, enabling clearer counseling.
Conclusions
Beyond detecting severe disorders, ES may help distinguish mild or manageable conditions from complex syndromes. In selected cases, it provides meaningful reassurance, reduces uncertainty, and supports informed prenatal decision‐making.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Genetics, Hadassah Medical Center, Jerusalem, Israel.
- Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Obstetrics and Gynecology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Maayane Hayeshua Medical Center, Gray Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Genetic Institute, Shamir Medical Center (Assaf Harofe), Gray Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
ORCID profiles: Jonathan Rips, Hagar Mor-Shaked, Shay Porat, Hagit Daum
Cite
APA
Rips, J., Mor-Shaked, H., Birnbaum, R., Eilat, A., Goldwicht, N., Porat, S., Erlik, U., Benyamini, L., & Daum, H. (2026). When Fetal Anomalies Lead to Prognostic Clarification: An Underrecognized Application of Exome Sequencing. Prenatal Diagnosis. https://doi.org/10.1002/pd.70239
Vancouver
Rips J, Mor-Shaked H, Birnbaum R, Eilat A, Goldwicht N, Porat S, et al. When Fetal Anomalies Lead to Prognostic Clarification: An Underrecognized Application of Exome Sequencing. Prenatal Diagnosis. 2026. doi:10.1002/pd.70239
BibTeX
@article{Rips2026,
author = {Rips, Jonathan and Mor-Shaked, Hagar and Birnbaum, Rivka and Eilat, Avital and Goldwicht, Natalie and Porat, Shay and Erlik, Uri and Benyamini, Lilach and Daum, Hagit},
title = {When Fetal Anomalies Lead to Prognostic Clarification: An Underrecognized Application of Exome Sequencing},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70239}
}
EUVIMED